drugset / Trial / NCT04170504

Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis

NCT04170504

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a multicenter, randomized, double-blinded, placebo-controlled trial with two parallel arms. The aim of the study is to evaluate whether Chinese herbal medicine Qing Re Huo Xue (QRHX) combined with methotrexate (MTX) might be better than Qing Re Huo Xue placebo combined with MTX for patients with active rheumatoid arthritis (RA).

Timeline

Start
2019-11-14
Primary completion
2022-06-28
Completion
2022-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Qing Re Huo Xue Traditional medicine (herbal / TCM) 10 g
Background Methotrexate Small molecule 10 mg Oral

Indications